Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review

Article ID	Journal	Published Year	Pages	File Type
8403752	Advanced Drug Delivery Reviews	2013	24 Pages	PDF

Keywords

ABC DDS MRP FDC HLB Bcrp MDM GRAS NRTIs PLA P-gp NBD R123 CFR US-FDA CMC DOX ATP-binding cassette superfamily Nanopharmaceuticals PCL MDR AUC P-glycoprotein U.S. Food and Drug Administration generally recognized as safe Tuberculosis Infectious diseases Fixed dose combinations hydrophilic–lipophilic balance Intravenous nucleotide-binding domain Antiretroviral therapy Doxorubicin Rhodamine 123 BCs Cancer biopharmaceutic classification system Drug delivery systems cyclodextrins Critical micellar concentration monocyte-derived macrophages Multidrug-resistant Multidrug resistance Nucleoside reverse transcriptase inhibitors Protease inhibitor Area-under-the-curve ART HBV HIV human immunodeficiency virus hepatitis B virus PAMAM multidrug resistance-associated protein breast cancer resistance protein Poly(epsilon-caprolactone)Poly(lactic acid)Poly(ethylene glycol)PEG Code of Federal Regulations

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology

Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review

Authors

Alejandro Sosnik,